Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.
The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.
The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.
In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.
In Science this week: random DNA replication errors play role in cancer, and more.
Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.
An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.
The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.
In Nature this week: genotypes linked to hip osteoarthritis, and more.
Startup companies are taking on personalized medicine, CNET reports.
Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.
The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.
Stanford's John Ioannidis and his team report on sources of bias in the scientific literature.
ScienceInsider reports that the Trump Administration budget blueprint may also include cuts to indirect costs.
Harvard researchers call for a discussion and development of guidelines for 'embryoid' research, NPR reports.
In PNAS this week: transcriptional patterns in breast cancer cell lines, study of non-CG methylation, and more.
A trial of a drug that mimics a PCSK9 gene mutation doesn't quite meet expectations, both Nature News and Forbes say.
CRISPR may make gene-editing easier, but it may also make regulation harder, according to New Scientist.
Buzzfeed News reports that Freenome CEO Gabriel Otte, despite some descriptions stating otherwise, did not receive a PhD.
In PLOS this week: COLEC10 linked to craniofacial development, transcripts and peptides of spider venom, and more.
UK regulators have given the clinic the green light to offer the service, the Guardian reports.
A survey of UK academics found that women tended to have higher teaching loads than men, according to Nature News.
A study appearing in PNAS finds that the mean age of the US scientific workforce is increasing.
At Science Careers, Princeton University's Julian West advises new researchers to read widely.
At Science Careers, a researcher describes how her rejuvenated postdoc science policy committee is promoting science.